Donepezil Could Delay Alzheimer’s Patients Move into Nursing Home

Donepezil Could Delay Alzheimer’s Patients Move into Nursing Home
U.K. researchers, headed by the Institute of Psychiatry, King's College London, have found that donepezil administered during the later stages of Alzheimer’s might temporarily decrease the likelihood that someone will need to move into a nursing home. The study report, entitled "Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses," appeared October 26 in the medical journal The Lancet.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *